Lenograstim administration to HLA-identical donor-recipient pairs to accelerate marrow recovery post-transplant

Bone Marrow Transplantation

Volumn 19, Issue 1, 1997, Pages 15-21

  Atkinson, K ^a,b   Fay, K ^a   Nivison Smith, I ^a   Downs, K ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

G CSF; Marrow and blood cell transplants

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DONOR; FEMALE; HLA MATCHING; HUMAN; IMMUNOADSORPTION; LEUKOCYTE COUNT; MALE; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SIBLING; STEM CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031028455     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700608     Document Type: Article

References (31)

1. Atkinson K (ed). Clinical Bone Marrow Transplantation: A Reference Textbook. Cambridge University Press: Cambridge, 1994.
2. Forman SJ, Blume KG, Thomas ED (eds). Bone Marrow Transplantation. Blackwell Scientific Publications: Boston, 1994.
3. Storb R, Deeg HJ, Whitehead J el al. Marrow transplantation for leukemia. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute-graft-versus host disease after marrow transplantation for leukemia. New Engl J Med 1986; 314: 729-735.
4. Atkinson K, Downs K, Golenia M et al. Prophylactic use of ganciclovir in allogeneic bone marrow transplantation: absence of clinical cytomegalovirus infection. Br J Haematol 1991; 79: 57-62.
5. Goodman JL, Winston DJ, Greenfield RA et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. New Engl J Med 1992; 326: 845-851.
6. Attal M, Huguet F, Rubie H. Prevention of hepatic venoocclusive disease after bone marrow transplantation by continuous infusion of low dose heparin: a prospective, randomised trial. Blood 1992; 79: 2834-2840.
7. Atkinson K, Biggs JC, Concannon AJ et al. Changing results of HLA-identical sibling bone marrow transplantation in patients with haematological malignancy during the period 1981-90. Aust NZ J Med 1993; 23: 181-186.
8. Sheridan WP, Begley CG, Juttner CA et al. Effect of peripheral blood progenitor cells mobilised by filgrastim (Ienograstim) on platelet recovery after high dose chemotherapy. Lancet 1992; 339: 640-644.
9. Janssen WE, Perkins J, Hiemenz JW et al. Granulocyte recovery is not different following auto transplant with lenograstim primed bone marrow or lenograstim mobilised peripheral blood 'stem cells'. Blood 1994; 84 (Suppl. 1): 95a.
10. Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilised by recombinant human granulocyte colony stimulating factor. Blood 1995; 85: 1655-1658.
11. Körbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1659-1665.
12. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral bood progenitor cells mobilised by filgrastim (granulocyte colony-stimulating factor). Blood 1995; 85: 1666-1672.
13. Kernan NA, Collins NH, Juliano L et al. Clonable T lymphocytes in T cell depleted bone marrow transplants correlate with development of graft versus host disease. Blood 1986; 68: 770-773.
14. Atkinson K, Farrelly H, Cooley M et al. Human marrow T cell dose correlates with severity of subsequent graft versus-host-disease. Bone Marrow Transplant 1987; 2: 51-57.
15. Berenson RJ, Bensinger WI, Hill RS et al. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 1991; 77: 1717-1722.
16. Thomas ED, Storb R. Technique for human marrow grafting. Blood 1970; 36: 507-515.
17. Atkinson K, Biggs JC, Ting A et al. Cyclosporin A is associated with faster engraftment and less mucositis than methotrexate after allogeneic bone marrow transplantation. Br J Haematol 1983; 53: 265-270.
18. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
19. Gisselbrecht C, Prentic HG, Bacigalupo A et al. Placebo-controlled phase III trial of lenograstim in bone marrow transplantation. Lancet 1994; 343: 696-700.
20. Lickliter JD, Roberts AW, Grigg AP. Phase II study of glycosylated recombinant human granulocyte colony-stimulating factor after HLA-identical sibling bone marrow transplantation. Aust NZ J Med 1994; 24: 541-546.
21. Martin-Algarra S, Bishop MR, Tarantolo S et al. Early administration of cytokines after related allogeneic bone marrow transplantation for hematological malignancies reduces duration of aplasia, hospital stay and treatment-related mortality. Blood 1994; 84 (Suppl. 1): 93a.
22. Kessinger A, Smith DM, Strandford SE et al. Allogeneic transplantation of blood derived T cell depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant 1989; 4: 643-646.
23. Russell NH, Hunter AE, Rogers S et al. Peripheral blood stem cells for allogeneic transplantation. Lancet 1993, 341: 1482 (letter).
24. Dreger P, Suttorp M, Haferlach T et al. Allogeneic granulocyte colony-stimulating factor-mobilised peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood 1993; 81: 1404-1407 (letter).
25. Sasaki A, Tsukaguchi M, Hirai M et al. Transplantation of allogeneic peripheral blood stem cells after myeloblative treatment of a patient in blastic crisis of chronic myelocytic leukemia. Am J Hematol 1994; 47: 45-49.
26. Nemunaitis J, Albo V, Zeigler ZR et al. Reduction of allogeneic transplant morbidity by combining peripheral blood and bone marrow progenitor cells. Leuk Lymphoma 1993; 10: 405-406.
27. Martinez JA, Picon I, Carral A et al. Allogeneic peripheral blood progenitor cells mobilised by G-CSF (filgrastim) for a second transplant in a patient with acute myeloid leukemia in relapse. Bone Marrow Transplant 1995; 15: 149-151.
28. Gürman G, Kahveci G, Akan H et al. Allogeneic peripheral blood stem cell transplantation as a second transplant for severe aplastic anemia. Bone Marrow Transplant 1995; 15: 485-486.
29. Molina L, Chabannon C, Viret F et al. Granulocyte colony-stimulating factor-mobilized allogeneic peripheral blood stem cells for rescue of graft failure after allogeneic bone marrow transplanation in two patients with acute myeloblastic leukemia in first complete remission. Blood 1995; 85: 1678-1679 (letter).
30. Chao NJ, Schmidt GM, Niland JC et al. Cyclosporine, methotrexate and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. New Engl J Med 1993; 329: 1225-1230.
31. Brugger W, Heinfeld S, Berenson RJ et al. Reconstitution of hematopoiesis after high dose chemotherapy by autologous progenitor cells generated ex vivo. New Engl J Med 1995; 333: 283-287.